Cargando…

Glucose‐induced cAMP elevation in β‐cells involves amplification of constitutive and glucagon‐activated GLP‐1 receptor signalling

AIM: cAMP typically signals downstream of G(s)‐coupled receptors and regulates numerous cell functions. In β‐cells, cAMP amplifies Ca(2+)‐triggered exocytosis of insulin granules. Glucose‐induced insulin secretion is associated with Ca(2+)‐ and metabolism‐dependent increases of the sub‐plasma‐membra...

Descripción completa

Detalles Bibliográficos
Autores principales: Shuai, Hongyan, Xu, Yunjian, Ahooghalandari, Parvin, Tengholm, Anders
Formato: Online Artículo Texto
Lenguaje:English
Publicado: John Wiley and Sons Inc. 2021
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047901/
https://www.ncbi.nlm.nih.gov/pubmed/33369112
http://dx.doi.org/10.1111/apha.13611
_version_ 1783679134895964160
author Shuai, Hongyan
Xu, Yunjian
Ahooghalandari, Parvin
Tengholm, Anders
author_facet Shuai, Hongyan
Xu, Yunjian
Ahooghalandari, Parvin
Tengholm, Anders
author_sort Shuai, Hongyan
collection PubMed
description AIM: cAMP typically signals downstream of G(s)‐coupled receptors and regulates numerous cell functions. In β‐cells, cAMP amplifies Ca(2+)‐triggered exocytosis of insulin granules. Glucose‐induced insulin secretion is associated with Ca(2+)‐ and metabolism‐dependent increases of the sub‐plasma‐membrane cAMP concentration ([cAMP](pm)) in β‐cells, but potential links to canonical receptor signalling are unclear. The aim of this study was to clarify the role of glucagon‐like peptide‐1 receptors (GLP1Rs) for glucose‐induced cAMP signalling in β‐cells. METHODS: Total internal reflection microscopy and fluorescent reporters were used to monitor changes in cAMP, Ca(2+) and ATP concentrations as well as insulin secretion in MIN6 cells and mouse and human β‐cells. Insulin release from mouse and human islets was also measured with ELISA. RESULTS: The GLP1R antagonist exendin‐(9‐39) (ex‐9) prevented both GLP1‐ and glucagon‐induced elevations of [cAMP](pm), consistent with GLP1Rs being involved in the action of glucagon. This conclusion was supported by lack of unspecific effects of the antagonist in a reporter cell‐line. Ex‐9 also suppressed IBMX‐ and glucose‐induced [cAMP](pm) elevations. Depolarization with K(+) triggered Ca(2+)‐dependent [cAMP](pm) elevation, an effect that was amplified by high glucose. Ex‐9 inhibited both the Ca(2+) and glucose‐metabolism‐dependent actions on [cAMP](pm). The drug remained effective after minimizing paracrine signalling by dispersing the islets and it reduced basal [cAMP](pm) in a cell‐line heterologously expressing GLP1Rs, indicating that there is constitutive GLP1R signalling. The ex‐9‐induced reduction of [cAMP](pm) in glucose‐stimulated β‐cells was paralleled by suppression of insulin secretion. CONCLUSION: Agonist‐independent and glucagon‐stimulated GLP1R signalling in β‐cells contributes to basal and glucose‐induced cAMP production and insulin secretion.
format Online
Article
Text
id pubmed-8047901
institution National Center for Biotechnology Information
language English
publishDate 2021
publisher John Wiley and Sons Inc.
record_format MEDLINE/PubMed
spelling pubmed-80479012021-04-16 Glucose‐induced cAMP elevation in β‐cells involves amplification of constitutive and glucagon‐activated GLP‐1 receptor signalling Shuai, Hongyan Xu, Yunjian Ahooghalandari, Parvin Tengholm, Anders Acta Physiol (Oxf) Metabolism and Nutritional Physiology AIM: cAMP typically signals downstream of G(s)‐coupled receptors and regulates numerous cell functions. In β‐cells, cAMP amplifies Ca(2+)‐triggered exocytosis of insulin granules. Glucose‐induced insulin secretion is associated with Ca(2+)‐ and metabolism‐dependent increases of the sub‐plasma‐membrane cAMP concentration ([cAMP](pm)) in β‐cells, but potential links to canonical receptor signalling are unclear. The aim of this study was to clarify the role of glucagon‐like peptide‐1 receptors (GLP1Rs) for glucose‐induced cAMP signalling in β‐cells. METHODS: Total internal reflection microscopy and fluorescent reporters were used to monitor changes in cAMP, Ca(2+) and ATP concentrations as well as insulin secretion in MIN6 cells and mouse and human β‐cells. Insulin release from mouse and human islets was also measured with ELISA. RESULTS: The GLP1R antagonist exendin‐(9‐39) (ex‐9) prevented both GLP1‐ and glucagon‐induced elevations of [cAMP](pm), consistent with GLP1Rs being involved in the action of glucagon. This conclusion was supported by lack of unspecific effects of the antagonist in a reporter cell‐line. Ex‐9 also suppressed IBMX‐ and glucose‐induced [cAMP](pm) elevations. Depolarization with K(+) triggered Ca(2+)‐dependent [cAMP](pm) elevation, an effect that was amplified by high glucose. Ex‐9 inhibited both the Ca(2+) and glucose‐metabolism‐dependent actions on [cAMP](pm). The drug remained effective after minimizing paracrine signalling by dispersing the islets and it reduced basal [cAMP](pm) in a cell‐line heterologously expressing GLP1Rs, indicating that there is constitutive GLP1R signalling. The ex‐9‐induced reduction of [cAMP](pm) in glucose‐stimulated β‐cells was paralleled by suppression of insulin secretion. CONCLUSION: Agonist‐independent and glucagon‐stimulated GLP1R signalling in β‐cells contributes to basal and glucose‐induced cAMP production and insulin secretion. John Wiley and Sons Inc. 2021-01-09 2021-04 /pmc/articles/PMC8047901/ /pubmed/33369112 http://dx.doi.org/10.1111/apha.13611 Text en © 2020 The Authors. Acta Physiologica published by John Wiley & Sons Ltd on behalf of Scandinavian Physiological Society. https://creativecommons.org/licenses/by-nc/4.0/This is an open access article under the terms of the http://creativecommons.org/licenses/by-nc/4.0/ (https://creativecommons.org/licenses/by-nc/4.0/) License, which permits use, distribution and reproduction in any medium, provided the original work is properly cited and is not used for commercial purposes.
spellingShingle Metabolism and Nutritional Physiology
Shuai, Hongyan
Xu, Yunjian
Ahooghalandari, Parvin
Tengholm, Anders
Glucose‐induced cAMP elevation in β‐cells involves amplification of constitutive and glucagon‐activated GLP‐1 receptor signalling
title Glucose‐induced cAMP elevation in β‐cells involves amplification of constitutive and glucagon‐activated GLP‐1 receptor signalling
title_full Glucose‐induced cAMP elevation in β‐cells involves amplification of constitutive and glucagon‐activated GLP‐1 receptor signalling
title_fullStr Glucose‐induced cAMP elevation in β‐cells involves amplification of constitutive and glucagon‐activated GLP‐1 receptor signalling
title_full_unstemmed Glucose‐induced cAMP elevation in β‐cells involves amplification of constitutive and glucagon‐activated GLP‐1 receptor signalling
title_short Glucose‐induced cAMP elevation in β‐cells involves amplification of constitutive and glucagon‐activated GLP‐1 receptor signalling
title_sort glucose‐induced camp elevation in β‐cells involves amplification of constitutive and glucagon‐activated glp‐1 receptor signalling
topic Metabolism and Nutritional Physiology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8047901/
https://www.ncbi.nlm.nih.gov/pubmed/33369112
http://dx.doi.org/10.1111/apha.13611
work_keys_str_mv AT shuaihongyan glucoseinducedcampelevationinbcellsinvolvesamplificationofconstitutiveandglucagonactivatedglp1receptorsignalling
AT xuyunjian glucoseinducedcampelevationinbcellsinvolvesamplificationofconstitutiveandglucagonactivatedglp1receptorsignalling
AT ahooghalandariparvin glucoseinducedcampelevationinbcellsinvolvesamplificationofconstitutiveandglucagonactivatedglp1receptorsignalling
AT tengholmanders glucoseinducedcampelevationinbcellsinvolvesamplificationofconstitutiveandglucagonactivatedglp1receptorsignalling